# A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients

> **NCT01757210** · — · COMPLETED · sponsor: **West Virginia University Healthcare** · enrollment: 20 (actual)

## Conditions studied

- Chemotherapy-Induced Nausea and Vomiting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01757210
- **Lead sponsor:** West Virginia University Healthcare
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757210, "A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01757210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*